Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,977 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aerie Pharmaceuticals, Inc. | $263.42 | 6 | $0 (2021) |
| ABBVIE INC. | $234.43 | 15 | $0 (2024) |
| Glaukos Corporation | $228.48 | 2 | $0 (2020) |
| Alcon Vision LLC | $183.89 | 4 | $0 (2022) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $172.30 | 12 | $0 (2021) |
| Shire North American Group Inc | $136.10 | 2 | $0 (2018) |
| Allergan, Inc. | $122.40 | 6 | $0 (2021) |
| EYEVANCE PHARMACEUTICALS LLC | $116.57 | 7 | $0 (2022) |
| Oyster Point Pharma, Inc. | $91.21 | 5 | $0 (2024) |
| Alcon Laboratories Inc | $84.74 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.06 | 9 | ABBVIE INC. ($69.13) |
| 2023 | $138.80 | 9 | AbbVie Inc. ($93.97) |
| 2022 | $170.86 | 11 | ABBVIE INC. ($71.33) |
| 2021 | $122.36 | 8 | Eyevance Pharmaceuticals LLC ($43.85) |
| 2020 | $507.49 | 12 | Aerie Pharmaceuticals, Inc. ($136.39) |
| 2019 | $304.52 | 9 | Aerie Pharmaceuticals, Inc. ($97.99) |
| 2018 | $336.33 | 15 | Shire North American Group Inc ($111.35) |
| 2017 | $240.11 | 5 | Glaukos Corporation ($109.14) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: EYE CARE | ||||||
| 10/09/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 08/14/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: EYE CARE | ||||||
| 07/22/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Ophthalmology | ||||||
| 07/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Dry eyes | ||||||
| 06/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: EYE CARE | ||||||
| 04/10/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: OPTOMETRY | ||||||
| 02/20/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: EYE CARE | ||||||
| 01/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Dry eyes | ||||||
| 12/13/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: EYE CARE | ||||||
| 12/12/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: EYE CARE | ||||||
| 07/11/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: EYE CARE | ||||||
| 06/05/2023 | Bausch & Lomb Americas Inc. | DOCTORS ALLERGY FORMULA (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Ophthalmology | ||||||
| 05/30/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: EYE CARE | ||||||
| 04/20/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: EYE CARE | ||||||
| 03/16/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: EYE CARE | ||||||
| 02/13/2023 | Bausch & Lomb Americas Inc. | DOCTORS ALLERGY FORMULA (Device) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Ophthalmology | ||||||
| 02/01/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: DRY EYE | ||||||
| 11/17/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: GLAUCOMA | ||||||
| 10/26/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: GLAUCOMA | ||||||
| 09/07/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: DRY EYE | ||||||
| 08/24/2022 | Alcon Vision LLC | rhopressa (Drug), rocklatan | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Glaucoma | ||||||
| 07/27/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: GLAUCOMA | ||||||
| 04/25/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: GLAUCOMA | ||||||
| 04/06/2022 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: GLAUCOMA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 413 | 460 | $39,424 | $24,261 |
| 2022 | 12 | 511 | 579 | $43,715 | $30,203 |
| 2021 | 11 | 500 | 543 | $49,459 | $35,454 |
| 2020 | 11 | 501 | 557 | $47,535 | $32,132 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 63 | 69 | $9,847 | $5,873 | 59.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 51 | 83 | $8,476 | $5,349 | 63.1% |
| 92273 | Measurement of retinal and optic nerve function | Office | 2023 | 31 | 32 | $4,834 | $3,710 | 76.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 37 | 37 | $6,201 | $3,305 | 53.3% |
| 92250 | Photography of the retina | Office | 2023 | 88 | 92 | $3,957 | $2,218 | 56.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 19 | 19 | $1,411 | $866.15 | 61.4% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 26 | 26 | $1,148 | $713.58 | 62.2% |
| 92025 | Ct scan of cornea | Office | 2023 | 24 | 24 | $988.39 | $703.90 | 71.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 22 | 22 | $952.96 | $576.67 | 60.5% |
| 92285 | Photography of content of eyes | Office | 2023 | 29 | 33 | $887.46 | $508.38 | 57.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 23 | 23 | $722.08 | $436.28 | 60.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 65 | 97 | $10,096 | $7,209 | 71.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 71 | 75 | $10,961 | $7,184 | 65.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 45 | 45 | $7,747 | $5,177 | 66.8% |
| 92250 | Photography of the retina | Office | 2022 | 116 | 118 | $5,070 | $3,433 | 67.7% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 25 | 26 | $1,913 | $1,410 | 73.7% |
| 92285 | Photography of content of eyes | Office | 2022 | 48 | 53 | $1,530 | $1,110 | 72.5% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2022 | 34 | 35 | $1,591 | $1,109 | 69.7% |
| 92025 | Ct scan of cornea | Office | 2022 | 36 | 36 | $1,512 | $1,088 | 72.0% |
| 76519 | Ultrasound scan to determine eye length and lens power | Office | 2022 | 11 | 33 | $1,241 | $998.57 | 80.5% |
| 92133 | Imaging of optic nerve | Office | 2022 | 25 | 26 | $1,107 | $754.71 | 68.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2022 | 23 | 23 | $734.94 | $574.39 | 78.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 12 | 12 | $211.80 | $155.88 | 73.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 41 | 41 | $7,865 | $7,848 | 99.8% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 57 | 81 | $8,471 | $6,201 | 73.2% |
About Dr. Joyce Varkey, D.O
Dr. Joyce Varkey, D.O is a Ophthalmology healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1912299892.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joyce Varkey, D.O has received a total of $1,977 in payments from pharmaceutical and medical device companies, with $156.06 received in 2024. These payments were reported across 78 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,977).
As a Medicare-enrolled provider, Varkey has provided services to 1,925 Medicare beneficiaries, totaling 2,139 services with total Medicare billing of $122,050. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Tulsa, OK
- Active Since 05/10/2011
- Last Updated 06/10/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912299892
Products in Payments
- DURYSTA (Drug) $327.45
- XIIDRA (Drug) $147.07
- rhopressa (Drug) $136.87
- AcrySof IQ PanOptix (Device) $119.38
- iStent inject Trabecular Micro-Bypass Stent System (Device) $119.34
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $109.14
- Rhopressa (Drug) $97.99
- TYRVAYA (Drug) $91.21
- Flarex (Drug) $87.20
- LOTEMAX GEL (Drug) $72.87
- LenSx (Device) $70.34
- rocklatan (Drug) $58.07
- ACTHAR (Biological) $46.31
- LOTEMAX SM (Drug) $38.06
- CRYSTALENS (Device) $31.30
- Tobradex ST (Drug) $29.37
- DOCTORS ALLERGY FORMULA (Device) $27.63
- Ahmed Glaucoma Valve (Device) $25.32
- INVELTYS (Drug) $21.57
- BromSite (bromfenac ophthalmic solution) 0.075% (Drug) $20.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Tulsa
Dr. Thomas Finley, Md, MD
Ophthalmology — Payments: $12,116
Dr. Kelli Dyer, D.o, D.O
Ophthalmology — Payments: $6,753
Jamal Siddiqui, M.d, M.D
Ophthalmology — Payments: $6,256
Neha Sangal
Ophthalmology — Payments: $4,653
Shehzad Batliwala, D.o, D.O
Ophthalmology — Payments: $4,278
Marc Goldberg, Md, MD
Ophthalmology — Payments: $4,188